Status:
COMPLETED
Diagnostic Reasoning With Customized GPT-4 Model
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Beth Israel Deaconess Medical Center
Conditions:
Pathologic Processes
Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study will assess the impact of immediate access to a customized version of GPT-4, a large language model, on performance in case-based diagnostic reasoning tasks. Specifically, it will compare t...
Detailed Description
Artificial intelligence (AI) technologies, particularly advanced large language models like OpenAI's ChatGPT, have the potential to enhance medical decision-making. While ChatGPT-4 was not specificall...
Eligibility Criteria
Inclusion
- Participants must be licensed physicians and have completed at least post-graduate year 1 (PGY1) of medical training.
- Training in Internal medicine, family medicine, or emergency medicine.
Exclusion
- Not currently practicing clinically.
- Participated in one of our previous studies that used the same six diagnostic cases.
Key Trial Info
Start Date :
December 16 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 24 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06911645
Start Date
December 16 2024
End Date
January 24 2025
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94305